Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. United by our vision to bring any therapy to life, we support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.

Our business is structured to meet our customers’ complex needs across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients. Our services and products span from supporting early-phase discovery to custom development and manufacturing of active pharmaceutical ingredients, as well as innovative dosage forms for the pharma and consumer health and nutrition industries. Our scale and resources mean that we can provide a single integrated solution to meet our customers’ complex needs.

Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. Our global community, of around 18,000 employees, is comprised of high-performing teams and individual talent that make a meaningful difference to our own business, as well as to the communities in which we operate. Our colleagues are the heart of our business and our global people strategy is designed to enable our colleagues to come, stay and grow at Lonza. While our business benefits from global supply chains, we have worked to maintain the agility to address marketplace needs on a local level.

Sustainable value creation is an ethical, social and commercial imperative for our business and supports us in fulfilling our purpose of enabling a healthier world. Across our global network, we create value by enhancing social engagement, strengthening our governance, and reducing our environmental footprint. We have grouped our sustainability initiatives around material themes and selected key Sustainable Development Goals (SDGs). The SDGs comprise the global blueprint of the United Nations (UN) to achieve a better and sustainable future for humanity. Learn more about our sustainability approach and initiatives within our Sustainability section of the website.

In Full-Year 2023, our company generated sales of CHF 6.7 billion with a CORE EBITDA of CHF 2.0 billion. Lonza shares are listed on the SIX Swiss Exchange and Swiss Market Index (SMI). We also maintain a secondary listing on the SGX Singapore Exchange.